TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
GSK

GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 8,409 million GBP. Tick rows to compare them in a chart.

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Income Statement GSK
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
8,147 8,052 7,363 7,884 8,012 8,117 7,516 7,986 8,547 8,618 7,629 8,409 33,203
2,272 2,418 1,970 2,122 2,397 2,559 1,937 2,165 2,258 2,657 1,875 2,266 9,056
5,875 5,634 5,393 5,762 5,615 5,558 5,579 5,821 6,289 5,961 5,754 6,143 24,147
1,575 2,047 1,434 1,477 1,459 2,031 1,462 2,024 1,689 2,350 1,692 3,466 9,197
2,296 2,678 2,087 2,465 3,800 2,663 2,070 2,140 2,239 2,639 2,119 2,202 9,199
3,926 5,061 3,903 4,116 5,426 4,862 3,363 3,798 3,696 4,455 3,461 5,662 17,274
1,949 573 1,490 1,646 189 696 2,216 2,023 2,593 1,506 2,293 481 6,873
182 275 166 174 156 144 162 184 167 174 167 182 690
1,791 379 1,355 1,495 64 563 2,108 1,887 2,456 950 2,144 354 5,904
257 -19 274 191 -1.0 62 336 241 312 223 305 -199 641
1,464 350 1,046 1,173 -58 414 1,624 1,443 2,013 636 1,737 435 4,821
2,552 1,157 2,070 2,308 1,171 1,119 3,093 3,230 3,361 1,907 2,774 2,826 10,868

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?